United States· US:50268-766_38f32e51-5ff7-7191-e063-6294a90ae02b

Terazosin

A medicinal product containing terazosin hydrochloride, registered in United States by AvPAK.

US label

Checked against FDA National Drug Code directory (United States) on September 27, 2026

Informational only — not a medical device.

Compare price across countriesPer daily dose · free account Ask the assistant about terazosin hydrochlorideAnswers with sources · free account Check interactionsSeverity free · mechanism on Growth

The record

At a glance

FDA National Drug Code directory (United States)

Active substance: TERAZOSIN HYDROCHLORIDE
Manufacturer: AvPAK
Country: United States (US)
ATC code: —
Reimbursed: Not published by this register
Source register: FDA National Drug Code directory (United States)
Last checked: September 27, 2026

Packs & prices · 2

ndc11
5026876615
50 BLISTER PACK in 1 BOX (50268-766-15) / 1 CAPSULE in 1 BLISTER PACK (50268-766-11)
ndc11
50268-766-15

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Terazosin hydrochloride in 14 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All terazosin hydrochloride products

Authorised across Europe · EMA

The same active substance is authorised in 20 EEA countries. Names it is sold under:

Austria · Uroflo, Vicard
Belgium · Hytrin, Terazosab
Czechia · Kornam
Germany · Heitrin, Tera Tad
Denmark · Sinalfa
Spain · Alfaprost, Mayul
France · Dysalfa, Hytrine
United Kingdom (Northern Ireland) · Hytrin, Terazosin
Greece · Hytrin
Hungary · Setegis
Ireland · Hytrin
Italy · Itrin, Prostatil
Luxembourg · Hytrin, Terazosab
Netherlands · Hytrin, Terazosine Accord
Norway · Sinalfa
Poland · Hytrin, Kornam
Portugal · Hytrin
Sweden · Sinalfa
Slovenia · Kornam
Slovakia · Kornam

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload

GET /v1/drugs/e3bd909d-1bf3-4182-91d6-a45f288a5a08
GET /v1/drugs/e3bd909d-1bf3-4182-91d6-a45f288a5a08?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "route": "ORAL",
  "source": "ndc",
  "strength": "5",
  "substance": "TERAZOSIN HYDROCHLORIDE",
  "productndc": "50268-766",
  "dosage_form": "CAPSULE",
  "dea_schedule": null,
  "strength_unit": "mg/1",
  "application_number": "ANDA075317",
  "marketing_category": "ANDA"
}

API reference MCP server Plans

See everything about terazosin hydrochloride.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it free Open in the console